Koshinski Asset Management
DCPH

Koshinski Asset Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Koshinski Asset Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100
Closed -$927 – 2055
2022
Q1 		$927 Hold
100
– – ﹤0.01% 2069
2021
Q4 		$977 Hold
100
– – ﹤0.01% 2078
2021
Q3 		$3.4K Buy
+100
New +$3.19K ﹤0.01% 1922

Other funds holding DCPH

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Koshinski Asset Management's DCPH Position: Q2 2022 in Review

Koshinski Asset Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2022, closing a stake of 100 shares — an estimated $927 sold.

Koshinski Asset Management first reported a position in DCPH in Q3 2021 and held it in 3 quarters. The position peaked at $3.4K in Q3 2021. 128 funds tracked by Wall St. Rank hold DCPH as of Q2 2022.

  • Koshinski Asset Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Koshinski Asset Management sold 100 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $927.
  • Koshinski Asset Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • Koshinski Asset Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $3.4K in Q3 2021.
  • 128 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on Koshinski Asset Management's 13F filing for Q2 2022, filed 12 Jul 2022.